Related Experiment Video
Updated: Jun 23, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Clinical and Laboratory Features of Sickle Cell Disease S/D Punjab: Impact of HbF and Hydroxyurea
S Alkindi1,2, I B M Al-Busaidi2, A V Pathare1
1Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
Insights
Sickle cell disease (SCD) patients with the SD Punjab genotype in Oman experience severe complications like vaso-occlusive crises and organ damage. Hydroxyurea treatment did not significantly improve outcomes or survival in this study cohort.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Sickle cell disease (SCD) is a global health concern with high morbidity and mortality.
- The SD Punjab genotype is the third most common SCD type in Oman, linked to severe complications.
- Understanding its clinical and laboratory features is crucial for patient management.
Purpose of the Study:
- To characterize the clinical and laboratory features of SCD patients with the SD Punjab genotype.
- To investigate the impact of hemoglobin F, hydroxyurea, and other modulators on disease severity.
Main Methods:
- Retrospective analysis of electronic medical records for 52 SCD patients with SD Punjab genotype (2006-2022).
- Data collection included SCD-related complications, clinical and laboratory indices.
- Comparison with historical controls of other SCD genotypes.
Main Results:
- The cohort (median age 32) experienced significant complications: Acute Chest Syndrome (48%), gallstones (26.9%), avascular necrosis (28.8%), and stroke (13.5%).
- Vaso-occlusive crises (VOC) ≥3 per year correlated with increased stroke, avascular necrosis, and gallstone incidence.
- Hydroxyurea use (19/33 patients) showed no impact on VOC, ACS, AVN, stroke, or mortality.
Conclusions:
- SD Punjab genotype in Oman presents with complications comparable to other SCD genotypes.
- Frequent VOC episodes are associated with a higher incidence of specific severe complications.
- Hydroxyurea did not demonstrate improved prognosis or survival in this SD Punjab cohort.
Background:
Sickle cell disease (SCD) is a major public health issue worldwide with high morbidity and mortality. SCD SD Punjab is the third most common genotype of SCD in Oman and is associated with several serious complications. The aim of the study is to establish the clinical and laboratory features of SCD patients with SD double heterozygotes and study the impact of haemoglobin F, hydroxyurea, and other modulators on the disease severity.
Methods:
We analysed the electronic medical records of 52 consecutive SCD patients who were diagnosed as double heterozygote SD Punjab between 2006 and 2022. The study was approved by the local medical research and ethics committee. The data captured included SCD-related complications and current clinical and laboratory indices. Data from other studies on other SCD genotypes were used as historical controls.
Results:
52 patients (31 males, 21 females) who formed this cohort had a median age of 32 years with an interquartile range (IQR) of 21-39.8 years. 37(71.2%) had <3 VOC per year, whereas 15 (28.8%) patients had ≥3 vasooclusive (VOC) episodes per year. SCD-related complications included Acute Chest Syndrome (ACS) (48%), Gall stones (26.9%), Avascular necrosis (AVN) (28.8%), Stroke (13.5%) and splenic sequestration (7.7%), whereas 5 (9.6%) patients of this cohort died. Surgical and Autosplenectomy were seen in 18 (34.6%). These findings were similar to other SCD genotypes in this community. 19 (57.6%) were taking Hydroxyurea (HU) amongst the 33 patients who were prescribed HU. Haematological parameters showed a median (IQR) Hb (g/dl), MCV (fl), Retic count (%), WBC count(×109/L) and Platelet count(×109/L) of 9.7 (8.5-11.3), 74.9 (68.4-79.8), 4 (3.2-5.7), 9.9 (8.1-12.6) and 309 (239-428) respectively. The haemoglobin electrophoresis showed an elevated HbF, whereas serum bilirubin and LDH were elevated amongst the biochemical parameters. The use of hydroxyurea showed no impact on VOC, ACS, AVN, Stroke or mortality.
Conclusion:
SD Punjab is the third most common SCD genotype in Oman and was associated with recurrent VOC, ACS, AVN, and gall stones comparable to other SCD genotypes. Patients with > 3 VOC/year had significantly increased incidence of Stroke, AVN, and gallstones. However, HU was not associated with improved prognosis and better survival in this cohort of patients.
Related Concept Videos
Multiple Allele Traits
Regulation of Hematopoietic Stem Cells
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

